CHARLES MCGEE: Open Payments
NPI 1811498959 · WHARTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$242 in 12 payments from 8 companies in 2025. Trend: 2023 $118 · 2024 $494 · 2025 $242
Food & beverage: $242
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Corcept Therapeutics | 1 | $22 |
| Optinose US, Inc. | 1 | $22 |
| Organogenesis Inc. | 1 | $21 |
| MIMEDX Group, Inc. | 1 | $21 |
Products named: OTEZLA, JARDIANCE, AIRSUPRA, NUZYRA, Korlym, Xhance, VIA MATRIX.
Industry payments across TX — which companies pay providers there.
